Modulation and Regulation of ROMK Channels in Kidney

$350,175R01FY2015DKNIH

New York Medical College, Valhalla NY

Investigators

Linked publications & trials

Paper 38096266 Paper 37823260 Paper 35759440 Paper 35506380 Paper 34843409 Paper 34229479 Paper 34029145 Paper 33900854 Paper 33818128 Paper 33749325 Paper 33719576 Paper 32789612 Paper 32308018 Paper 32255763 Paper 31865783 Paper 31736353 Paper 31239388 Paper 31064772 Paper 31013253 Paper 30875275 Paper 30623727 Paper 30571558 Paper 30559144 Paper 30517856 Paper 30484345 Paper 29915013 Paper 29897283 Paper 29483225 Paper 29412704 Paper 29310825 Paper 29141174 Paper 29031361 Paper 28705920 Paper 28604387 Paper 28365586 Paper 28356287 Paper 28178566 Paper 28052988 Paper 27806944 Paper 27306796 Paper 27122539 Paper 27122158 Paper 26887833 Paper 26728465 Paper 26330658 Paper 26319417 Paper 25848073 Paper 25834074 Paper 25805816 Paper 25565204 Paper 25100281 Paper 25099735 Paper 25071208 Paper 24370594 Paper 24197061 Paper 23873931 Paper 23673010 Paper 23569086 Paper 23235481 Paper 22575459 Paper 22513846 Paper 22050992 Paper 21566059 Paper 21311022 Paper 20927043 Paper 20601877 Paper 20357031 Paper 19710010 Paper 19706464 Paper 19656909 Paper 19211683 Paper 18839206 Paper 18211905 Paper 17538186 Paper 17517644 Paper 17164397 Paper 16971657 Paper 16543729 Paper 16339961 Paper 16204406 Paper 15772303 Paper 15767585 Paper 15644319 Paper 15618483 Paper 15300162 Paper 15265768 Paper 15151916 Paper 15130898 Paper 15075184 Paper 14977413 Paper 14600033 Paper 12890664 Paper 12684792 Paper 12556363 Paper 12221079 Paper 12217858 Paper 12130653 Paper 12007740 Paper 11880329 Paper 11719519

Abstract

DESCRIPTION (provided by applicant): With-No-Lysine Kinase 4 (WNK4) plays an important role in regulating Na and K transport in the aldosterone-sensitive distal nephron (ASDN). Mutation of WNK4 causes familial hyperkalemic hypertension, an autosomal dominant disease characterized by salt-sensitive hypertension, hyperkalemia and renal tubule acidosis (Pseudohypoaldosteronism type II). A large body of evidence shows that WNK4 inhibits ROMK, regulates ENaC and modulates the paracellular Cl permeability in the collecting duct. The inhibitory effect of WNK4 on ROMK is attenuated by serum-glucocorticoid- induced kinase1 (SGK1)-mediated phosphorylation of WNK4 in the switch-domain. Recently, we have further demonstrated that Src-family protein tyrosine kinases (SFK), such as c-Src, phosphorylates WNK4 and diminishes SGK1-induced phosphorylation of WNK4 thereby restoring the inhibitory effect of WNK4 on ROMK channels. The interaction among WNK4, SFK and SGK1 plays an important role in stimulating K secretion during increasing K intake and in preventing K loss during volume depletion. However, the molecular mechanism by which c-Src modulates the interaction of SGK1 with WNK4 is not understood. The goal of the present proposal is to test the hypothesis that SFK-mediated phosphorylation of WNK4 activates protein phosphatase 1 (PP1) thereby abolishing the SGK1-induced stimulation of WNK4 phosphorylation and restoring the inhibitory effect of WNK4 on ROMK1. Specific Aim 1 is to test the hypothesis that c-Src binds and phosphorylates WNK4 and that the Tyr phosphorylation of WNK4 abolishes SGK1-induced phosphorylation at WNK4's switch domain thereby locking WNK4 in inhibitory mode for ROMK. Specific Aim 2 is to test the hypothesis that PP1 binds to WNK4 and is involved in mediating the effect of c-Src on WNK4-induced inhibition of ROMK. Specific Aim 3 is to test the hypothesis that PTP1D binds to WNK4, modulates PP1 activity and participates in the interaction among SGK1, WNK4 and c- Src, a mechanism which specifically regulates ROMK but has no effect on ENaC. The significance of the project is to expand the current understanding regarding the regulation of Na and K transport in the ASDN and to provide an integrated mechanism of WNK4-mediated regulation of ROMK in the ASDN.

View original record on NIH RePORTER →